Menu

Akoya Biosciences, Inc. AKYA

Full chart Compare
Set alert

Price alert · AKYA

All alert types
1.29 0.00 (+0.00%)

At closeJul 8, 2025, 4:00 PM EDT

1.29 Day range 1.29
1.88 52-week range 6.31

Revenue & Expenses

Other Income → Expenses: $2.45MExpenses → Selling, General & Admin: $69.32MExpenses → Research & Development: $19.75MExpenses → Other Operating Expenses: $6.06MExpenses → Interest Expense: $10.43MExpenses → Income Tax: $146.00KGross Profit → Expenses: $47.88MRevenue → Gross Profit: $47.88MRevenue → Cost of Revenue: $33.79MNet Loss → Expenses: $55.37MOther Income$2.45MGross Profit$47.88MNet Loss$55.37MCost of Revenue$33.79MExpenses$105.69MSelling, General & Admin$69.32MResearch & Development$19.75MOther Operating Expenses$6.06MInterest Expense$10.43MIncome Tax$146.00KRevenue$81.67M

Latest period ending Dec 31, 2024 · select a line to chart its full history

AKYA annual income statement
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
81.67M96.63M74.86M54.92M42.44M
47.88M56.30M43.39M34.22M25.91M
-47.24M-56.03M-66.21M-37.23M-11.49M
-55.37M-63.32M-70.64M-42.94M-16.71M
-1.12-1.43-1.87-1.65-9.18
AKYA annual balance sheet
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
12.46M83.82M74.53M113.38M17.01M
125.00M180.37M176.03M190.91M77.66M
117.41M126.60M117.45M69.56M59.58M
84.15M85.71M75.78M32.94M34.99M
7.59M53.77M58.58M121.35M-51.03M
AKYA annual cash flow
Fiscal yearFY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021FY 2020 Dec 31, 2020
-44.10M-50.90M-53.50M-36.07M-6.84M
-24.05M3.35M-14.08M-5.09M6.73M
-3.21M56.84M28.73M137.03M5.49M
-2.46M-3.65M-7.30M-5.09M-3.29M
-71.36M9.29M-38.85M95.87M5.37M